Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Corcept Therapeutics Inc (CORT)  
$22.80 0.59 (2.66%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 116,630,000
Market Cap: 2.66(B)
Last Volume: 820,436 Avg Vol: 990,000
52 Week Range: $21.1 - $33.8
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Corcept Therapeutics is a commercial-stage company engaged in the discovery and development of drugs that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effects of the hormone cortisol. Co. has marketed Korlym (mifepristone) in the U.S. for the treatment of patients with Cushing's syndrome. Co.'s primary compounds have entered the clinic as potential treatments for serious disorders, including Cushing's syndrome, solid tumors (such as ovarian cancer, castration-resistant prostate cancer and adrenocortical cancer with cortisol excess), antipsychotic induced weight gain and non-alcoholic steatohepatitis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 88,543 140,536 318,791 928,421
Total Sell Value $2,237,891 $3,635,678 $8,712,718 $24,481,747
Total People Sold 3 5 7 8
Total Sell Transactions 10 18 37 55
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 487
  Page 9 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lyon Joseph Douglas Chief Accounting Officer   •       –      –    2021-03-01 4 AS $25.21 $630,320 D/D (25,000) 0 -13%     
   Lyon Joseph Douglas Chief Accounting Officer   •       –      –    2021-03-01 4 OE $8.27 $206,750 D/D 25,000 25,000     -
   Maduck Sean See Remarks   •       –      –    2021-02-16 4 S $28.25 $253,903 D/D (8,989) 30,024 19%     
   Maduck Sean See Remarks   •       –      –    2021-02-16 4 OE $3.29 $29,574 D/D 8,989 39,013     -
   Robb Gary Charles Chief Financial Officer   •       –      –    2021-02-12 4 S $28.22 $3,163,899 D/D (112,100) 85,638 19%     
   Robb Gary Charles Chief Financial Officer   •       –      –    2021-02-11 4 S $29.78 $101,249 D/D (3,400) 197,738 22%     
   Maduck Sean See Remarks   •       –      –    2021-02-11 4 S $29.78 $101,249 D/D (3,400) 30,024 22%     
   Maduck Sean See Remarks   •       –      –    2021-02-11 4 OE $3.29 $11,186 D/D 3,400 33,424     -
   Lyon Joseph Douglas Chief Accounting Officer   •       –      –    2021-02-03 4 AS $29.18 $729,570 D/D (25,000) 0 -24%     
   Lyon Joseph Douglas Chief Accounting Officer   •       –      –    2021-02-03 4 OE $8.27 $206,750 D/D 25,000 25,000     -
   Robb Gary Charles Chief Financial Officer   •       –      –    2021-01-22 4 D $28.06 $7,260,216 D/D (258,739) 201,138     -
   Robb Gary Charles Chief Financial Officer   •       –      –    2021-01-22 4 OE $2.70 $1,220,000 D/D 451,852 459,877     -
   Belanoff Joseph K Chief Executive Officer   •       •      –    2021-01-22 4 D $28.06 $13,499,329 D/D (481,088) 2,818,126     -
   Belanoff Joseph K Chief Executive Officer   •       •      –    2021-01-22 4 OE $4.42 $3,536,000 D/D 800,000 3,299,214     -
   Wilson James N Director   –       •      –    2021-01-21 4 GD $0.00 $0 I/I 12,000 1,162,845     -
   Swisher Daniel N Jr Director   –       •      –    2021-01-19 4 AS $28.74 $143,687 D/D (5,000) 0 -25%     
   Swisher Daniel N Jr Director   –       •      –    2021-01-19 4 OE $6.55 $32,750 D/D 5,000 5,000     -
   Baker G Leonard Jr Director   •       •      –    2020-12-01 4 B $22.64 $1,540 I/I 68 3,208,303 2.02 -3%     
   Baker G Leonard Jr Director   •       •      –    2020-11-30 4 B $22.80 $25,285 I/I 1,109 3,208,235 2.1 -1%     
   Baker G Leonard Jr Director   •       •      –    2020-11-25 4 B $22.81 $8,233 I/I 361 3,207,126 2.1 0%     
   Hunt Hazel Chief Scientific Officer   •       –      –    2020-11-24 4 D $22.88 $714,428 D/D (31,225) 18,975     -
   Hunt Hazel Chief Scientific Officer   •       –      –    2020-11-24 4 OE $3.96 $198,000 D/D 50,000 50,200     -
   Baker G Leonard Jr Director   •       •      –    2020-11-24 4 B $22.93 $32,766 I/I 1,429 3,206,765 2.1 2%     
   Baker G Leonard Jr Director   •       •      –    2020-11-23 4 B $22.93 $35,562 I/I 1,551 3,205,336 2.1 5%     
   Baker G Leonard Jr Director   •       •      –    2020-11-18 4 B $17.91 $42,491 I/I 2,372 3,203,785 2.1 27%     
  487 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us